Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SYRE
Stock Latest News
The Fly
Wedbush biotech analyst holds an analyst/industry conference call
6d ago
MLTX
ORKA
Premium
Company Announcements
Spyre Therapeutics Reports Positive Phase 2 SKYLINE Data
19d ago
8K
SYRE
Premium
The Fly
Spyre Therapeutics announces 12-week induction data from Part A of SKYLINE trial
19d ago
SYRE
Premium
The Fly
Midday Fly By: Meta to settle addiction trial, Intuit resets outlook
1M ago
LI
TH
Premium
The Fly
Spyre Therapeutics falls -13.2%
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics falls -11.6%
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target lowered to $123 from $130 at Wedbush
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target lowered to $121 from $132 at BTIG
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target lowered to $127 from $135 at Deutsche Bank
1M ago
SYRE
Premium
The Fly
Closing Bell Movers: Intuit slides 9% on disappointing guidance
1M ago
ZM
BOX
Premium
Market News
Spyre Therapeutics Stock (SYRE) Tumbles 14% in After-Hours – Here’s What Spooked Investors
1M ago
SYRE
Premium
Company Announcements
Spyre Therapeutics reports Phase 2 TL1A trial results
1M ago
8K
SYRE
Premium
The Fly
Spyre Therapeutics announces results from RA sub-study of SKYWAY basket trial
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $130 from $100 at Wedbush
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $120 from $90 at Baird
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $130 from $115 at Guggenheim
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $115 from $90 at Wells Fargo
2M ago
SYRE
Premium
Ratings
Spyre Therapeutics: Buy Rating Reiterated on Robust Pipeline, IBD Strategy and Strong Cash Runway; $112 Price Target Maintained
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics reports Q2 EPS (36c), consensus (75c)
2M ago
SYRE
Premium
Ratings
Spyre Therapeutics: Merck TL1A Readthrough Supports Multi-Disease Opportunity, Solid Cash Runway, and Unchanged $119 Buy Target
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
2M ago
SYRE
Premium
The Fly
Spyre Therapeutics price target raised to $120 from $84 at Mizuho
3M ago
SYRE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
